Bio Roundup: Amarin’s Stunner, Lung Cancer News, Data Dumps & More
Xconomy
SEPTEMBER 28, 2018
Sales lagged. While other groups tested other fish oils and found no evidence of concrete cardiovascular benefits , Amarin pressed on with a massive study, bleeding cash for years. But Amarin didn’t have the evidence that lowering triglycerides with fish oil would really help people. Amarin’s shares sank.
Let's personalize your content